This opportunity is no longer accepting applications.
grant RFA-CA-24-028

Limited Competition: AIDS Malignancy Consortium (AMC; UM1 Clinical Trial Required)

The National Cancer Institute (NCI) is offering funding for the AIDS Malignancy Consortium (AMC) to support research on HIV-related cancers. The AMC will focus on developing and evaluating treatments and prevention methods for these cancers, studying their biology, and managing global issues related to them. It will distribute tumor samples and other biological materials to a cancer research r…

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to enable the provision of support for AIDS Malignancy Consortium (AMC). AMC is a major infrastructure intended to stimulate cooperative research efforts in the following areas: Design, development, an…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Dates

Opportunity Released: August 13, 2024
Open for Submission: August 13, 2024
Submission Deadline: January 10, 2025
Application Window Closes: January 10, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.